PROCEDYTE: Depocyte® Administration (Liposomal Cytarabine) as Prophylaxis of Neuromeningeal Infiltration in Acute Lymphoblastic Leukemia
NCT00944008
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
7
Enrollment
OTHER
Sponsor class
Conditions
Acute Lymphoblastic Leukemia
Interventions
DRUG:
DepoCyte
Sponsor
PETHEMA Foundation